Thromboelastography with citrated blood: Comparability with native blood, stability of citrate storage and effect of repeated sampling

Andrea Zambruni, Ulrich Thalheimer, Gioacchino Leandro, David Perry, Andrew K. Burroughs

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Thromboelastography (TEG) with recalcified citrate blood is used as an alternative to native blood, but there is insufficient data regarding sample reliability and stability over time. Thus, TEG parameters of freshly drawn native blood were compared with those of recalcified citrated blood without celite in 10 healthy subjects, and the effect of repeated sampling over 240-min storage was evaluated. All TEG parameters following citrate storage remained stable between 30 min [clot formation time (k) = 7.2 ± 0.6 min; maximum amplitude (ma) = 48.5 ± 1.9 mm] and 2 h (k = 7.1 ± 0.6 min; ma = 46.2 ± 2.5 mm) after initial sampling, but were not comparable with native blood (k = 9.3 ± 0.7 min; ma = 43.5 ± 2.5 mm) at any time point. TEG parameters of repeatedly sampled citrated blood had a significant overall hypercoagulable trend throughout 4 h following sampling. In conclusion, in order to achieve reproducible results, citrated blood without celite may be utilized between 30 min and 2 h following sampling, but in normal subjects the TEG parameters following citrate storage are not comparable with native blood, possibly because of incomplete inhibition of the activation of the coagulation cascade. Thus, citrated blood can be used as a surrogate of native blood in assessing coagulation using TEG, but if repeated sampling is used the trend in hypercoagulability must be considered.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalBlood Coagulation and Fibrinolysis
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Thrombelastography
Citric Acid
Diatomaceous Earth
Thrombophilia
Healthy Volunteers

Keywords

  • Citrate
  • Coagulation
  • Storage
  • Thromboelastography

ASJC Scopus subject areas

  • Hematology

Cite this

Thromboelastography with citrated blood : Comparability with native blood, stability of citrate storage and effect of repeated sampling. / Zambruni, Andrea; Thalheimer, Ulrich; Leandro, Gioacchino; Perry, David; Burroughs, Andrew K.

In: Blood Coagulation and Fibrinolysis, Vol. 15, No. 1, 01.2004, p. 103-107.

Research output: Contribution to journalArticle

@article{ef7fe72f2dd740729e0e09822d66a85a,
title = "Thromboelastography with citrated blood: Comparability with native blood, stability of citrate storage and effect of repeated sampling",
abstract = "Thromboelastography (TEG) with recalcified citrate blood is used as an alternative to native blood, but there is insufficient data regarding sample reliability and stability over time. Thus, TEG parameters of freshly drawn native blood were compared with those of recalcified citrated blood without celite in 10 healthy subjects, and the effect of repeated sampling over 240-min storage was evaluated. All TEG parameters following citrate storage remained stable between 30 min [clot formation time (k) = 7.2 ± 0.6 min; maximum amplitude (ma) = 48.5 ± 1.9 mm] and 2 h (k = 7.1 ± 0.6 min; ma = 46.2 ± 2.5 mm) after initial sampling, but were not comparable with native blood (k = 9.3 ± 0.7 min; ma = 43.5 ± 2.5 mm) at any time point. TEG parameters of repeatedly sampled citrated blood had a significant overall hypercoagulable trend throughout 4 h following sampling. In conclusion, in order to achieve reproducible results, citrated blood without celite may be utilized between 30 min and 2 h following sampling, but in normal subjects the TEG parameters following citrate storage are not comparable with native blood, possibly because of incomplete inhibition of the activation of the coagulation cascade. Thus, citrated blood can be used as a surrogate of native blood in assessing coagulation using TEG, but if repeated sampling is used the trend in hypercoagulability must be considered.",
keywords = "Citrate, Coagulation, Storage, Thromboelastography",
author = "Andrea Zambruni and Ulrich Thalheimer and Gioacchino Leandro and David Perry and Burroughs, {Andrew K.}",
year = "2004",
month = "1",
doi = "10.1097/00001721-200401000-00017",
language = "English",
volume = "15",
pages = "103--107",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Thromboelastography with citrated blood

T2 - Comparability with native blood, stability of citrate storage and effect of repeated sampling

AU - Zambruni, Andrea

AU - Thalheimer, Ulrich

AU - Leandro, Gioacchino

AU - Perry, David

AU - Burroughs, Andrew K.

PY - 2004/1

Y1 - 2004/1

N2 - Thromboelastography (TEG) with recalcified citrate blood is used as an alternative to native blood, but there is insufficient data regarding sample reliability and stability over time. Thus, TEG parameters of freshly drawn native blood were compared with those of recalcified citrated blood without celite in 10 healthy subjects, and the effect of repeated sampling over 240-min storage was evaluated. All TEG parameters following citrate storage remained stable between 30 min [clot formation time (k) = 7.2 ± 0.6 min; maximum amplitude (ma) = 48.5 ± 1.9 mm] and 2 h (k = 7.1 ± 0.6 min; ma = 46.2 ± 2.5 mm) after initial sampling, but were not comparable with native blood (k = 9.3 ± 0.7 min; ma = 43.5 ± 2.5 mm) at any time point. TEG parameters of repeatedly sampled citrated blood had a significant overall hypercoagulable trend throughout 4 h following sampling. In conclusion, in order to achieve reproducible results, citrated blood without celite may be utilized between 30 min and 2 h following sampling, but in normal subjects the TEG parameters following citrate storage are not comparable with native blood, possibly because of incomplete inhibition of the activation of the coagulation cascade. Thus, citrated blood can be used as a surrogate of native blood in assessing coagulation using TEG, but if repeated sampling is used the trend in hypercoagulability must be considered.

AB - Thromboelastography (TEG) with recalcified citrate blood is used as an alternative to native blood, but there is insufficient data regarding sample reliability and stability over time. Thus, TEG parameters of freshly drawn native blood were compared with those of recalcified citrated blood without celite in 10 healthy subjects, and the effect of repeated sampling over 240-min storage was evaluated. All TEG parameters following citrate storage remained stable between 30 min [clot formation time (k) = 7.2 ± 0.6 min; maximum amplitude (ma) = 48.5 ± 1.9 mm] and 2 h (k = 7.1 ± 0.6 min; ma = 46.2 ± 2.5 mm) after initial sampling, but were not comparable with native blood (k = 9.3 ± 0.7 min; ma = 43.5 ± 2.5 mm) at any time point. TEG parameters of repeatedly sampled citrated blood had a significant overall hypercoagulable trend throughout 4 h following sampling. In conclusion, in order to achieve reproducible results, citrated blood without celite may be utilized between 30 min and 2 h following sampling, but in normal subjects the TEG parameters following citrate storage are not comparable with native blood, possibly because of incomplete inhibition of the activation of the coagulation cascade. Thus, citrated blood can be used as a surrogate of native blood in assessing coagulation using TEG, but if repeated sampling is used the trend in hypercoagulability must be considered.

KW - Citrate

KW - Coagulation

KW - Storage

KW - Thromboelastography

UR - http://www.scopus.com/inward/record.url?scp=2042441122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2042441122&partnerID=8YFLogxK

U2 - 10.1097/00001721-200401000-00017

DO - 10.1097/00001721-200401000-00017

M3 - Article

C2 - 15166952

AN - SCOPUS:2042441122

VL - 15

SP - 103

EP - 107

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 1

ER -